Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option

Sep 28, 2026

Some deaths in Utah never come under the authority of the state Office of the Medical Examiner, which leaves families without a postmortem examination.

SALT LAKE CITY - Sept. 28, 2026 - PRLog -- Postmortem Pathology, a nationwide practice offering private autopsy services in Salt Lake City and across the Wasatch Front, exists to close that gap.

State medical examiner authority in Utah reaches only a fraction of deaths, somewhere near one in three. The office logged 7,899 death investigations over the course of 2023. Its mandate covers deaths that arrive without warning, involve violence, or carry circumstances no physician can readily explain. Even inside that mandate, a full autopsy is not automatic.

What remains is a large category of Utah families standing outside the system altogether. A parent dies in an assisted living facility. A relative is certified as a natural death while the family suspects a diagnosis was missed. A sudden cardiac death raises the question of whether surviving children carry the same inherited risk. In each case, a private autopsy in Salt Lake City is frequently the only way forward.

"Families come to us because the question they are asking is not the question the state system is built to answer," said Dr. Dan Lingamfelter, lead pathologist at Postmortem Pathology. "A death can be entirely expected from a legal standpoint and still leave a family with no idea what actually happened medically. That gap is where we work."

Timing matters as much as access. For families working against probate deadlines, insurance filing windows, or civil claims governed by fixed limitation periods, an independent autopsy in Salt Lake City can be booked directly and delivered on an agreed schedule.

Record access is a third consideration. Utah statute shields medical examiner files from open release. Attorneys who want them must first establish standing, ordinarily through written authorization from the legal next of kin, appointment by a court as representative of the estate, or a subpoena or order issued by a judge. An examination commissioned privately produces a report that belongs to the family or their counsel from day one.

Postmortem Pathology is run by pathologists holding board certification in anatomic, clinical, and forensic pathology, with case experience spanning criminal and civil proceedings. A standard examination covers inspection of the body inside and out, screening for drugs and toxins, and microscopic study of tissue. Pricing opens at $5,000. Findings stay confidential and are released only to the family or the parties they designate.

Families and attorneys pursuing Independent autopsy services in Salt Lake City can contact Postmortem Pathology directly to review case specifics, scheduling, and coordination with whichever funeral home or facility currently holds the decedent.

About Postmortem Pathology

Postmortem Pathology is a private autopsy and forensic pathology practice staffed by pathologists board certified in anatomic, clinical, and forensic pathology. The firm handles cases in all 50 states, including private autopsy services in Salt Lake City and throughout Utah, working with families, attorneys, insurers, and treating physicians. More information is available at postmortempath.com.

Contact
Matthew Tropp
***@blackthornpublishing.com


Source: Blackthorn Publishing

Read Full Story - Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option | More news from this source

Press release distribution by PRLog
MORE NEWS
AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows
Sep 29, 2026
AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows

Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further underscored the sector’s global momentum amid easing fears of US curbs. AstraZeneca on Tuesday announced a US$2 billion equity investment in Florida-headquartered Summit Therapeutics, which holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China. Summit and AstraZeneca would...

Domestic workers in Central Visayas to get P500 monthly minimum wage increase
Sep 29, 2026
Domestic workers in Central Visayas to get P500 monthly minimum wage increase

Domestic workers will receive a P500 increase in their monthly minimum wage under a new wage order in Central Visayas, the Department of Labor and Employment (DOLE) said Tuesday.

‘180-degree flip’ sees global investors turn to China for diversification: Pimco president
Sep 29, 2026
‘180-degree flip’ sees global investors turn to China for diversification: Pimco president

Global investors are turning to China again in search of alternatives to crowded US asset markets, with Pimco seeing Chinese bonds as one of the safest ways to diversify portfolios after sentiment towards the world’s second-largest economy “flipped 180 degrees”. The US-based asset manager, which oversaw more than US$2 trillion in assets by the end of June, had been pointing its clients, particularly those outside the United States, towards Chinese offshore bonds, according to its president,...

DOE pushes competitive framework for nuclear power procurement
Sep 29, 2026
DOE pushes competitive framework for nuclear power procurement

As the Philippines moves to include nuclear power in its energy mix, the Department of Energy (DOE) is pushing for a competitive procurement framework focused on strict grid readiness, staged delivery schedules, and rigorous pricing parameters.

Hong Kong’s IPO revival faces test as 3 new stocks stumble on debut
Sep 29, 2026
Hong Kong’s IPO revival faces test as 3 new stocks stumble on debut

Hong Kong welcomed four companies to start trading on Tuesday after they raised a combined HK$14.4 billion (US$1.83 billion) – but three opened below their offer prices, adding pressure to an already sluggish month for initial public offerings (IPOs). Automated equipment manufacturer RoboTechnik Intelligent Technology was the largest company to make its debut, having raised HK$5.18 billion, but its shares closed 4.9 per cent lower at HK$414.4 (US$52.82) after dropping as much as 9.8 per...

Why is JPMorgan expanding in China? CEO Dimon sees another decade of sharp growth
Sep 29, 2026
Why is JPMorgan expanding in China? CEO Dimon sees another decade of sharp growth

JPMorgan Chase, the world’s top bank by market capitalisation, plans to expand hiring and technology investment across mainland China and Hong Kong and is looking to take advantage of the city’s strengthening capital markets as well as its platform for serving companies operating in and out of the Chinese market, according to senior executives. CEO Jamie Dimon said the banking giant’s China-related business, measured by factors including client volume, has grown sharply over the past decade –...

Chinese brokerages get in line with Beijing’s crackdown on overseas stock trading
Sep 29, 2026
Chinese brokerages get in line with Beijing’s crackdown on overseas stock trading

Some securities companies have begun to clean up non-compliant overseas stock trading by mainland Chinese investors following a regulatory crackdown that started months ago with fines on Tiger Brokers and Futu Securities International. Orient Securities’ mainland-based clients that have trading accounts in its Hong Kong unit will be banned from buying stocks and transferring in funds starting on Wednesday, according to a notice to customers seen by the South China Morning Post. Guotai Junan...

AMD acquires ‘godmother of AI’ Li Fei-Fei’s start-up as battle with Nvidia intensifies
Sep 29, 2026
AMD acquires ‘godmother of AI’ Li Fei-Fei’s start-up as battle with Nvidia intensifies

US chip giant Advanced Micro Devices (AMD) has agreed to acquire World Labs, the artificial intelligence start-up founded by renowned Chinese-American computer scientist Li Fei-Fei, for US$8.2 billion in an all-stock deal, as the company steps up its rivalry with Nvidia. The acquisition, expected to close by the end of this year, would integrate World Labs’ research team and spatial-intelligence model expertise into AMD, according to an announcement on Monday. Li, a Stanford University professor...

Meralco begins search for suppliers of 900-MW power requirement
Sep 29, 2026
Meralco begins search for suppliers of 900-MW power requirement

The Manila Electric Company (Meralco) on Tuesday announced that it has started the bidding or competitive selection process (CSP) for suppliers of its 900-megawatt (MW) baseload power requirement.

DOE to require oil firms to submit monthly info on fuel costs
Sep 29, 2026
DOE to require oil firms to submit monthly info on fuel costs

The Department of Energy (DOE) said Tuesday the suspension of excise taxes on liquefied petroleum gas (LPG) and kerosene would provide direct relief to Filipino households amid elevated global oil prices.

Future-ready: how Asia’s wealthiest should plan for the age of longevity
Sep 29, 2026
Future-ready: how Asia’s wealthiest should plan for the age of longevity

[The content of this article has been produced by our advertising partner.] Going by the figures alone, there is no escaping just how important investment in future planning has become for Asia’s high-net-worth (HNW) and ultra-high-net-worth (UHNW) families, with industry watchers predicting they will drive an estimated US$5.8 trillion in asset transfers in the region by 2030. But behind these figures lie some lingering questions, chief among them being how much investment can be considered...

Shein drops 14% to record low after profit misses in first results since Hong Kong IPO
Sep 29, 2026
Shein drops 14% to record low after profit misses in first results since Hong Kong IPO

Shares of Shein Global Holdings fell as much as 14 per cent to a record low in Hong Kong on Tuesday after the online fashion retailer posted a 67 per cent drop in second-quarter profit in its first earnings report since listing, warning that tariff headwinds and logistics cost volatility would persist for the rest of the year. The stock sank to as low as HK$30.24 during the day and closed 10.7 per cent down at HK$31.50. Both the intraday and closing prices hit their lowest levels since the...

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.